Antibiotic prescriptions for lung problems dropped during COVID-19 restrictions in Australia

Publicly released:
Australia; NSW; VIC
NOVAMOXIN_antibiotic By Bmramon at English Wikipedia, CC BY-SA 3.0
NOVAMOXIN_antibiotic By Bmramon at English Wikipedia, CC BY-SA 3.0

An Australian and Icelandic analysis of national claims data reveals that community dispensing of antibiotics primarily used to treat respiratory infections dropped during COVID-19 restrictions in Australia, but antibiotics for non-respiratory infections remained unchanged. In regions with high rates of COVID-19 spread, such as Europe and the United States, prescriptions for antibiotics in the community dropped dramatically after COVID-19 restrictions were introduced, so these researchers decided to look at antibiotic prescribing in Australia, which has had low COVID-19 rates. The researchers say these big reductions show how low general practitioners’ antibiotic prescribing could go if guidelines were followed more closely, as antibiotics should only rarely be prescribed for common viral respiratory infections.

Media release

From: Wiley

Investigators examine antibiotic prescribing following COVID-19 restrictions

In regions with high rates of COVID-19 spread, such as Europe and the United States, prescriptions for antibiotics in the community dropped dramatically after COVID-19 restrictions were introduced in early 2020. A study published in the British Journal of Clinical Pharmacology looked at antibiotic prescribing in Australia, which has had low COVID-19 rates.

Analyses of national claims data revealed that COVID-19 restrictions in Australia were associated with substantial reductions in community dispensing of antibiotics primarily used to treat respiratory infections, but antibiotics for non-respiratory infections were unchanged.

“The issue is that antibiotics should rarely be prescribed for common viral respiratory infections in the first place. These big reductions show how low general practitioners’ antibiotic prescribing could go if guidelines were followed more closely,” said co–senior Helga Zoega, PhD, of UNSW Sydney, in Australia.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Wiley, Web page The URL will go live after the embargo ends
Journal/
conference:
British Journal of Clinical Pharmacology
Research:Paper
Organisation/s: The University of New South Wales, Murdoch Children's Research Institute (MCRI), The University of Melbourne, The University of Sydney, Doherty Institute for Infection and Immunity
Funder: UNSW Scientia Program; Financial Markets Foundation for Children, Grant/Award Number: APP1197940; National Health and Medical Research Council, Grant/Award Numbers: 1158763, 1175744, 1196900
Media Contact/s
Contact details are only visible to registered journalists.